Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Exercise training and cytokines in breast cancer survivors
Gomez AM, Martinez C, Fiuza-Luces C, Herrero F, Perez M, Madero L, Ruiz JR, Lucia A, Ramirez M
International Journal of Sports Medicine 2011 Jun;32(6):461-467
clinical trial
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

The purpose of this randomized controlled trial was to determine the effects of an 8-week (aerobic+strength) exercise training program (3 sessions/week) on the circulating cytokine levels of breast cancer survivors. We randomly allocated 16 female survivors of breast cancer (mean +/- SD age 50 +/- 5 years) to an intervention or usual care (control) group (n = 8 in each group). The intervention group followed an 8-week exercise program consisting of 3 sessions/week (session duration: 90min). We measured the levels of the following cytokines before and after the intervention: beta-NGF, CTACK, eotaxin, FGF basic, G-CSF, gmCSFalpha, HGF, ICAM1, IFNalpha2, IFNgamma, IL1alpha, IL1s, IL1ra, IL2, IL2ra, IL3, IL4, IL6, IL7, IL8, IL9, IL10, IL12, IL13, IL15, IL16, IL17, IL18, IP10, LIF, MCS-F, MIP1alpha, MIP1beta, MIF, MCP1, MCP3, MIG, PDGF bb, SCF, SCGFbeta, SDF1alpha, TRAIL, TNFalpha, TNFbeta, VCAM1, and VEGF. We only observed a significant interaction (group x time) effect for CTACK (p = 0.016), with mean values remaining stable in the intervention group but increasing over time in controls. The intervention program did not induce a significant decrease in the main breast cancer-related cytokines such as IL6 and IL8. A combined (aerobic+strength) 8-week exercise training intervention did not induce major changes in the basal cytokine levels of breast cancer survivors.

Full text (sometimes free) may be available at these link(s):      help